Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 5,351 | 6,224 | 5,722 | 7,192 | 7,432 |
| Operating Income | -5,351 | -6,224 | -5,722 | -7,192 | -7,432 |
| Interest Expense | -15 | -17 | 1 | 2 | 3 |
| Other Income | 0 | 0 | 0 | -23 | 0 |
| Pre-tax Income | -5,336 | -6,208 | -5,723 | -7,217 | -7,435 |
| Income Tax | N/A | -2 | 5 | N/A | N/A |
| Net Income Continuous | -5,336 | -6,205 | -5,728 | -7,217 | -7,435 |
| Net Income | $-5,336 | $-6,210 | $-5,723 | $-7,217 | $-7,435 |
| EPS Basic Total Ops | -3.90 | -4.50 | -4.80 | -7.21 | -9.01 |
| EPS Basic Continuous Ops | -3.76 | -4.37 | -4.64 | -7.06 | -8.65 |
| EPS Diluted Total Ops | -3.90 | -4.50 | -4.80 | -7.21 | -9.01 |
| EPS Diluted Continuous Ops | -3.76 | -4.37 | -4.64 | -7.06 | -8.65 |
| EBITDA(a) | $-5,230 | $-6,188 | $-5,853 | $-6,913 | $-7,384 |